JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilotte, N. S.
Right arrow Articles by Kuhar, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilotte, N. S.
Right arrow Articles by Kuhar, M. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*COCAINE

Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats

NS Pilotte, LG Sharpe and MJ Kuhar

Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland.

Male, Lewis rats were administered cocaine or saline i.v. in an intermittent fashion for 5, 10 or 20 days and killed at various times afterwards. Dopamine transporter binding was then measured in dorsal striatum and nucleus accumbens. Transporter binding was not changed in dorsal striatum under any conditions tested. In the nucleus accumbens, however, binding was decreased in animals given cocaine (10 mg/kg total) for 10 days and withdrawn for 10, 30 or 60 days, but not in animals withdrawn for 0, 1, 3 and 6 days. There were no changes in animals given cocaine for 5 days and withdrawn for 10, or in animals given drug for 20 days and withdrawn for 1 day. Animals given only 1/10 of the cocaine dose had no changes in nucleus accumbens after 10 days of administration and 10 days of withdrawal. Scatchard analysis in control animals indicated that there were significant differences in both Kd and Bmax when comparing nucleus accumbens with dorsal striatum. Within the nucleus accumbens, decreases in binding after a cessation of cocaine administration were associated with a change in Bmax and not in Kd. These data indicate that long-lasting changes in the mesolimbic dopaminergic system can occur during the withdrawal period, and may contribute to behavioral effects during this period.

Volume 269, Issue 3, pp. 963-969, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. L. Borgland, R. C. Malenka, and A. Bonci
Acute and Chronic Cocaine-Induced Potentiation of Synaptic Strength in the Ventral Tegmental Area: Electrophysiological and Behavioral Correlates in Individual Rats
J. Neurosci., August 25, 2004; 24(34): 7482 - 7490.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Sabeti, G. A. Gerhardt, and N. R. Zahniser
Individual Differences in Cocaine-Induced Locomotor Sensitization in Low and High Cocaine Locomotor-Responding Rats Are Associated with Differential Inhibition of Dopamine Clearance in Nucleus Accumbens
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 180 - 190.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. L. Kimmel, F. I. Carroll, and M. J. Kuhar
Withdrawal from Repeated Cocaine Alters Dopamine Transporter Protein Turnover in the Rat Striatum
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. R. Letchworth, M. A. Nader, H. R. Smith, D. P. Friedman, and L. J. Porrino
Progression of Changes in Dopamine Transporter Binding Site Density as a Result of Cocaine Self-Administration in Rhesus Monkeys
J. Neurosci., April 15, 2001; 21(8): 2799 - 2807.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Fang and O. K. Ronnekleiv
Cocaine Upregulates the Dopamine Transporter in Fetal Rhesus Monkey Brain
J. Neurosci., October 15, 1999; 19(20): 8966 - 8978.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
K. Y. Little, D. P. McLaughlin, L. Zhang, P. R. McFinton, G. W. Dalack, E. H. Cook Jr, B. J. Cassin, and S. J. Watson
Brain Dopamine Transporter Messenger RNA and Binding Sites in Cocaine Users: A Postmortem Study
Arch Gen Psychiatry, September 1, 1998; 55(9): 793 - 799.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. R. Tella, B. Ladenheim, A. M. Andrews, S. R. Goldberg, and J. L. Cadet
Differential Reinforcing Effects of Cocaine and GBR-12909: Biochemical Evidence for Divergent Neuroadaptive Changes in the Mesolimbic Dopaminergic System
J. Neurosci., December 1, 1996; 16(23): 7416 - 7427.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
S. G. Amara
Monoamine Transporters: Basic Biology with Clinical Implications
Neuroscientist, September 1, 1995; 1(5): 259 - 267.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.